These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30188604)

  • 1. Positive familial history for metabolic traits predisposes to early and more severe alcoholic cirrhosis: A cross-sectional study.
    Bhadoria AS; Kedarisetty CK; Bihari C; Kumar G; Jindal A; Bhardwaj A; Shasthry V; Benjamin J; Sharma MK; Sarin SK
    Liver Int; 2019 Jan; 39(1):168-176. PubMed ID: 30188604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of family history of metabolic traits on severity of non-alcoholic steatohepatitis related cirrhosis: A cross-sectional study.
    Bhadoria AS; Kedarisetty CK; Bihari C; Kumar G; Jindal A; Bhardwaj A; Shasthry V; Vyas T; Benjamin J; Sharma S; Sharma MK; Sarin SK
    Liver Int; 2017 Sep; 37(9):1397-1404. PubMed ID: 28231412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
    Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia--a historical cohort study.
    Jepsen P; Ott P; Andersen PK; Vilstrup H
    BMC Res Notes; 2012 Sep; 5():509. PubMed ID: 22988833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of alcohol-related cirrhosis at a tertiary care center in North East India.
    Bhattacharyya M; Barman NN; Goswami B
    Indian J Gastroenterol; 2016 May; 35(3):167-72. PubMed ID: 27146041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32.
    Degré D; Stauber RE; Englebert G; Sarocchi F; Verset L; Rainer F; Spindelboeck W; Njimi H; Trépo E; Gustot T; Lackner C; Deltenre P; Moreno C
    J Hepatol; 2020 Apr; 72(4):636-642. PubMed ID: 31954208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
    Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
    Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
    Alvarez MA; Cirera I; Solà R; Bargalló A; Morillas RM; Planas R
    J Clin Gastroenterol; 2011; 45(10):906-11. PubMed ID: 21814145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
    Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alcoholic fatty liver, alcoholic hepatitis and alcoholic cirrhosis. Drinking behavior and incidence of clinical, clinico-chemical and histological findings in 282 patients].
    Bode JC; Kruse G; Mexas P; Martini GA
    Dtsch Med Wochenschr; 1984 Oct; 109(40):1516-21. PubMed ID: 6236965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population.
    Hung WC; Wu JS; Sun ZJ; Lu FH; Yang YC; Chang CJ
    BMJ Open; 2016 Nov; 6(11):e013106. PubMed ID: 27852719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
    Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
    Hepatology; 2010 May; 51(5):1675-82. PubMed ID: 20186844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
    Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
    Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes.
    Apostolov R; Wong D; Low E; Vaz K; Spurio J; Worland T; Liu D; Chan RK; Gow P; Grossmann M; Sinclair M
    Scand J Gastroenterol; 2023; 58(11):1328-1334. PubMed ID: 37282344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol-attributable healthcare attendances up to 10 years prior to diagnosis of alcoholic cirrhosis: a population based case-control study.
    Otete HE; Orton E; Fleming KM; West J
    Liver Int; 2016 Apr; 36(4):538-46. PubMed ID: 26560966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.
    Nagpal SJ; Kabbany MN; Mohamad B; Lopez R; Zein NN; Alkhouri N
    Dig Dis Sci; 2016 Jul; 61(7):2102-7. PubMed ID: 26993824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
    Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
    J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
    Zhang M; Wu R; Jiang J; Minuk GY; Niu J
    Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.